{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,30]],"date-time":"2026-03-30T13:14:06Z","timestamp":1774876446645,"version":"3.50.1"},"reference-count":219,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Immunopharmacology"],"published-print":{"date-parts":[[2023,4]]},"DOI":"10.1016\/j.intimp.2023.109945","type":"journal-article","created":{"date-parts":[[2023,3,3]],"date-time":"2023-03-03T12:35:14Z","timestamp":1677846914000},"page":"109945","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":19,"special_numbering":"C","title":["Preclinical study models of psoriasis: State-of-the-art techniques for testing pharmaceutical products in animal and nonanimal models"],"prefix":"10.1016","volume":"117","author":[{"given":"Krishna","family":"Yadav","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Deependra","family":"Singh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Manju Rawat","family":"Singh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sunita","family":"Minz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S","family":"Princely Ebenezer Gnanakani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"family":"Sucheta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Renu","family":"Yadav","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lalitkumar","family":"Vora","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kantrol Kumar","family":"Sahu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anindya","family":"Bagchi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nagendra","family":"Singh Chauhan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Madhulika","family":"Pradhan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.intimp.2023.109945_b0005","doi-asserted-by":"crossref","first-page":"170","DOI":"10.7861\/clinmed.2021-0257","article-title":"Psoriasis: a brief overview","volume":"21","author":"Raharja","year":"2021","journal-title":"Clin. Med."},{"key":"10.1016\/j.intimp.2023.109945_b0010","doi-asserted-by":"crossref","DOI":"10.3390\/ijms20061475","article-title":"Psoriasis Pathogenesis and Treatment","volume":"20","author":"Rendon","year":"2019","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.intimp.2023.109945_b0015","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1007\/s12016-018-8668-1","article-title":"Psoriasis: from Pathogenesis to Targeted Therapies","volume":"54","author":"Conrad","year":"2018","journal-title":"Clin. Rev. Allergy Immunol."},{"key":"10.1016\/j.intimp.2023.109945_b0020","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/j.cpm.2016.02.004","article-title":"Psoriasis: Pathogenesis, Assessment, and Therapeutic Update","volume":"33","author":"Schleicher","year":"2016","journal-title":"Clin. Podiatr. Med. Surg."},{"key":"10.1016\/j.intimp.2023.109945_b0025","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.880201","article-title":"Epidemiology of Psoriasis and Comorbid Diseases: A Narrative Review","volume":"13","author":"Bu","year":"2022","journal-title":"Front. Immunol."},{"key":"10.1016\/j.intimp.2023.109945_b0030","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1016\/j.clindermatol.2007.08.014","article-title":"Animal models of psoriasis","volume":"25","author":"Boehncke","year":"2007","journal-title":"Clin. Dermatol."},{"key":"10.1016\/j.intimp.2023.109945_b0035","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1016\/j.jaci.2020.04.034","article-title":"Animal models of psoriasis\u2014highlights and drawbacks","volume":"147","author":"Sch\u00f6n","year":"2021","journal-title":"J. Allergy Clin. Immunol."},{"key":"10.1016\/j.intimp.2023.109945_b0040","series-title":"Animal Models of Psoriasis and Psoriatic Arthritis BT - Psoriatic Arthritis and Psoriasis: Pathology and Clinical Aspects","first-page":"103","author":"Lories","year":"2016"},{"key":"10.1016\/j.intimp.2023.109945_b0045","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1084\/jem.20031482","article-title":"Spontaneous development of psoriasis in a new animal model shows an essential role for resident T cells and tumor necrosis factor-alpha","volume":"199","author":"Boyman","year":"2004","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.intimp.2023.109945_b0050","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1016\/j.cyto.2014.12.014","article-title":"Cytokines in psoriasis","volume":"73","author":"Baliwag","year":"2015","journal-title":"Cytokine"},{"key":"10.1016\/j.intimp.2023.109945_b0055","series-title":"Transl","first-page":"361","article-title":"Chapter 16 - Targeting autoimmune disorders through metal nanoformulation in overcoming the fences of conventional treatment approaches","author":"Yadav","year":"2022"},{"key":"10.1016\/j.intimp.2023.109945_b0060","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1038\/labinvest.3780339","article-title":"Anti-CD11a ameliorates disease in the human psoriatic skin-SCID mouse transplant model: comparison of antibody to CD11a with Cyclosporin A and clobetasol propionate","volume":"81","author":"Zeigler","year":"2001","journal-title":"Lab. Invest."},{"key":"10.1016\/j.intimp.2023.109945_b0065","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1111\/ajt.13520","article-title":"Humanized Mouse Models for Transplant Immunology","volume":"16","author":"Kenney","year":"2016","journal-title":"Am. J. Transplant. Off. J. Am. Soc. Transplant. Am. Soc. Transpl. Surg."},{"key":"10.1016\/j.intimp.2023.109945_b0070","doi-asserted-by":"crossref","first-page":"1548","DOI":"10.1172\/JCI110409","article-title":"Involved and uninvolved skin from psoriatic subjects: are they equally diseased? Assessment by skin transplanted to congenitally athymic (nude) mice","volume":"68","author":"Krueger","year":"1981","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.intimp.2023.109945_b0075","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1111\/j.1600-065X.1999.tb01317.x","article-title":"Inflammatory disease in HLA-B27 transgenic rats","volume":"169","author":"Taurog","year":"1999","journal-title":"Immunol. Rev."},{"key":"10.1016\/j.intimp.2023.109945_b0080","doi-asserted-by":"crossref","first-page":"R769","DOI":"10.1186\/ar1728","article-title":"A monoclonal antibody against kininogen reduces inflammation in the HLA-B27 transgenic rat","volume":"7","author":"Keith","year":"2005","journal-title":"Arthritis Res. Ther."},{"key":"10.1016\/j.intimp.2023.109945_b0085","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1038\/jid.2012.390","article-title":"CD8(+) T cells mediate RAS-induced psoriasis-like skin inflammation through IFN-\u03b3","volume":"133","author":"Gunderson","year":"2013","journal-title":"J, Invest. Dermatol."},{"key":"10.1016\/j.intimp.2023.109945_b0090","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1016\/0092-8674(95)90211-2","article-title":"Suprabasal integrin expression in the epidermis of transgenic mice results in developmental defects and a phenotype resembling psoriasis","volume":"83","author":"Carroll","year":"1995","journal-title":"Cell"},{"key":"10.1016\/j.intimp.2023.109945_b0095","doi-asserted-by":"crossref","first-page":"19798","DOI":"10.1074\/jbc.M300513200","article-title":"Regulation of Interleukin-1\u03b1 Expression by Integrins and Epidermal Growth Factor Receptor in Keratinocytes from a Mouse Model of Inflammatory Skin Disease*","volume":"278","author":"Hobbs","year":"2003","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.intimp.2023.109945_b0100","doi-asserted-by":"crossref","first-page":"1100","DOI":"10.1038\/jid.2009.43","article-title":"Key Role of Macrophages in the Pathogenesis of CD18 Hypomorphic Murine Model of Psoriasis","volume":"129","author":"Wang","year":"2009","journal-title":"J, Invest. Dermatol."},{"key":"10.1016\/j.intimp.2023.109945_b0105","doi-asserted-by":"crossref","first-page":"1443","DOI":"10.2353\/ajpath.2009.080858","article-title":"Keratinocyte but not endothelial cell-specific overexpression of Tie2 leads to the development of psoriasis","volume":"174","author":"Wolfram","year":"2009","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.intimp.2023.109945_b0110","doi-asserted-by":"crossref","first-page":"71","DOI":"10.4049\/jimmunol.1700995","article-title":"Essential Role of CARD14 in Murine Experimental Psoriasis","volume":"200","author":"Tanaka","year":"2018","journal-title":"J. Immunol."},{"key":"10.1016\/j.intimp.2023.109945_b0115","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1046\/j.1523-1747.2003.12002.x","article-title":"Bone Morphogenetic Proteins and Their Antagonists in Skin and Hair Follicle Biology","volume":"120","author":"Botchkarev","year":"2003","journal-title":"J, Invest. Dermatol."},{"key":"10.1016\/j.intimp.2023.109945_b0120","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1038\/jid.2009.252","article-title":"A role for TGFbeta signaling in the pathogenesis of psoriasis","volume":"130","author":"Han","year":"2010","journal-title":"J, Invest. Dermatol."},{"key":"10.1016\/j.intimp.2023.109945_b0125","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1111\/j.1600-0625.2006.00431.x","article-title":"Prevention of psoriasis-like lesions development in fsn\/fsn mice by helminth glycans","volume":"15","author":"Atochina","year":"2006","journal-title":"Exp. Dermatol."},{"key":"10.1016\/j.intimp.2023.109945_b0130","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1046\/j.1365-2249.2001.01421.x","article-title":"Pathogenic function of IL-1 beta in psoriasiform skin lesions of flaky skin (fsn\/fsn) mice","volume":"123","author":"Sch\u00f6n","year":"2001","journal-title":"Clin. Exp. Immunol."},{"key":"10.1016\/j.intimp.2023.109945_b0135","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1038\/JID.2015.362","article-title":"Differential Features between Chronic Skin Inflammatory Diseases Revealed in Skin-Humanized Psoriasis and Atopic Dermatitis Mouse Models","volume":"136","author":"Carretero","year":"2016","journal-title":"J, Invest. Dermatol."},{"key":"10.1016\/j.intimp.2023.109945_b0140","doi-asserted-by":"crossref","first-page":"1292","DOI":"10.1038\/sj.jid.5700807","article-title":"Mouse Models of Psoriasis","volume":"127","author":"Gudjonsson","year":"2007","journal-title":"J, Invest. Dermatol."},{"key":"10.1016\/j.intimp.2023.109945_b0145","doi-asserted-by":"crossref","first-page":"1420","DOI":"10.1038\/s41467-018-03704-z","article-title":"Epigenetic control of IL-23 expression in keratinocytes is important for chronic skin inflammation","volume":"9","author":"Li","year":"2018","journal-title":"Nat. Commun."},{"key":"10.1016\/j.intimp.2023.109945_b0150","doi-asserted-by":"crossref","first-page":"e71","DOI":"10.1002\/cpim.71","article-title":"IL-23- and Imiquimod-Induced Models of Experimental Psoriasis in Mice","volume":"125","author":"Singh","year":"2019","journal-title":"Curr. Protoc. Immunol."},{"key":"10.1016\/j.intimp.2023.109945_b0155","doi-asserted-by":"crossref","first-page":"1495","DOI":"10.4049\/jimmunol.1001001","article-title":"IL-23-mediated psoriasis-like epidermal hyperplasia is dependent on IL-17A","volume":"186","author":"Rizzo","year":"2011","journal-title":"J. Immunol."},{"key":"10.1016\/j.intimp.2023.109945_b0160","doi-asserted-by":"crossref","first-page":"e0194667","DOI":"10.1371\/journal.pone.0194667","article-title":"The severity of imiquimod-induced mouse skin inflammation is independent of endogenous IL-38 expression","volume":"13","author":"Palomo","year":"2018","journal-title":"PLoS One"},{"key":"10.1016\/j.intimp.2023.109945_b0165","doi-asserted-by":"crossref","first-page":"5836","DOI":"10.4049\/jimmunol.0802999","article-title":"Imiquimod-induced psoriasis-like skin inflammation in mice is mediated via the IL-23\/IL-17 axis","volume":"182","author":"van der Fits","year":"2009","journal-title":"J. Immunol."},{"key":"10.1016\/j.intimp.2023.109945_b0170","doi-asserted-by":"crossref","first-page":"3065","DOI":"10.4049\/jimmunol.1300348","article-title":"Th17 cells carrying TCR recognizing epidermal autoantigen induce psoriasis-like skin inflammation","volume":"191","author":"Nishimoto","year":"2013","journal-title":"J. Immunol."},{"key":"10.1016\/j.intimp.2023.109945_b0175","first-page":"597","article-title":"IL-22 is required for Th17 cell-mediated pathology in a mouse model of psoriasis-like skin inflammation","volume":"118","author":"Ma","year":"2008","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.intimp.2023.109945_b0180","doi-asserted-by":"crossref","unstructured":"D. Singh, M. Pradhan, S. Shrivastava, S.N. Murthy, M.R. Singh, Chapter 11 - Skin autoimmune disorders: lipid biopolymers and colloidal delivery systems for topical delivery, in: A.M.B.T.-N. in G.F. and C. Grumezescu (Ed.), William Andrew Publishing, 2016: pp. 257\u2013296. https:\/\/doi.org\/https:\/\/doi.org\/10.1016\/B978-0-323-42868-2.00011-5.","DOI":"10.1016\/B978-0-323-42868-2.00011-5"},{"key":"10.1016\/j.intimp.2023.109945_b0185","article-title":"Topical delivery of fluocinolone acetonide integrated NLCs and salicylic acid enriched gel: A potential and synergistic approach in the management of psoriasis","volume":"61","author":"Pradhan","year":"2021","journal-title":"J. Drug Deliv. Sci. Technol."},{"key":"10.1016\/j.intimp.2023.109945_b0190","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.chemphyslip.2014.11.004","article-title":"Development characterization and skin permeating potential of lipid based novel delivery system for topical treatment of psoriasis","volume":"186","author":"Pradhan","year":"2015","journal-title":"Chem. Phys. Lipids"},{"key":"10.1016\/j.intimp.2023.109945_b0195","doi-asserted-by":"crossref","unstructured":"M. Pradhan, A. Alexander, M.R. Singh, D. Singh, S. Saraf, S. Saraf, K. Yadav, Ajazuddin, Statistically optimized calcipotriol fused nanostructured lipid carriers for effectual topical treatment of psoriasis, J. Drug Deliv. Sci. Technol. (2020) 102168. https:\/\/doi.org\/https:\/\/doi.org\/10.1016\/j.jddst.2020.102168.","DOI":"10.1016\/j.jddst.2020.102168"},{"key":"10.1016\/j.intimp.2023.109945_b0200","doi-asserted-by":"crossref","unstructured":"A.A. Chis, C. Dobrea, C. Morgovan, A.M. Arseniu, L.L. Rus, A. Butuca, A.M. Juncan, M. Totan, A.L. Vonica-Tincu, G. Cormos, A.C. Muntean, M.L. Muresan, F.G. Gligor, A. Frum, Applications and Limitations of Dendrimers in Biomedicine., Molecules. 25 (2020). https:\/\/doi.org\/10.3390\/molecules25173982.","DOI":"10.3390\/molecules25173982"},{"key":"10.1016\/j.intimp.2023.109945_b0205","doi-asserted-by":"crossref","first-page":"7","DOI":"10.4103\/0019-5154.48977","article-title":"Current concepts in the pathogenesis of psoriasis","volume":"54","author":"Das","year":"2009","journal-title":"Indian J. Dermatol."},{"key":"10.1016\/j.intimp.2023.109945_b0210","doi-asserted-by":"crossref","DOI":"10.3390\/vaccines8030517","article-title":"Immunomodulatory Role of the Antimicrobial LL-37 Peptide in Autoimmune Diseases and Viral Infections","volume":"8","author":"Pahar","year":"2020","journal-title":"Vaccines"},{"key":"10.1016\/j.intimp.2023.109945_b0215","doi-asserted-by":"crossref","first-page":"8349712","DOI":"10.1155\/2020\/8349712","article-title":"Significance of LL-37 on Immunomodulation and Disease Outcome","volume":"2020","author":"Yang","year":"2020","journal-title":"Biomed. Res. Int."},{"key":"10.1016\/j.intimp.2023.109945_b0220","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.1038\/jid.2011.458","article-title":"A Single Intradermal Injection of IFN-\u03b3 Induces an Inflammatory State in Both Non-Lesional Psoriatic and Healthy Skin","volume":"132","author":"Johnson-Huang","year":"2012","journal-title":"J, Invest. Dermatol."},{"key":"10.1016\/j.intimp.2023.109945_b0225","article-title":"Nanovesicles delivery approach for targeting steroid mediated mechanism of antipsoriatic therapeutics","volume":"65","author":"Yadav","year":"2021","journal-title":"J. Drug Deliv. Sci. Technol."},{"key":"10.1016\/j.intimp.2023.109945_b0230","doi-asserted-by":"crossref","first-page":"1549","DOI":"10.3389\/fimmu.2018.01549","article-title":"The Interplay Between Keratinocytes and Immune Cells in the Pathogenesis of Psoriasis","volume":"9","author":"Albanesi","year":"2018","journal-title":"Front. Immunol."},{"key":"10.1016\/j.intimp.2023.109945_b0235","doi-asserted-by":"crossref","first-page":"e12945","DOI":"10.1111\/sji.12945","article-title":"Current knowledge on autoantigens and autoantibodies in psoriasis","volume":"92","author":"Ten Bergen","year":"2020","journal-title":"Scand. J. Immunol."},{"key":"10.1016\/j.intimp.2023.109945_b0240","doi-asserted-by":"crossref","first-page":"5621","DOI":"10.1038\/ncomms6621","article-title":"The antimicrobial peptide LL37 is a T-cell autoantigen in psoriasis","volume":"5","author":"Lande","year":"2014","journal-title":"Nat. Commun."},{"key":"10.1016\/j.intimp.2023.109945_b0245","doi-asserted-by":"crossref","unstructured":"S.K. Ippagunta, R. Gangwar, D. Finkelstein, P. Vogel, S. Pelletier, S. Gingras, V. Redecke, H. H\u00e4cker, Keratinocytes contribute intrinsically to psoriasis upon loss of Tnip1 function., Proc. Natl. Acad. Sci. U. S. A. 113 (2016) E6162\u2013E6171. https:\/\/doi.org\/10.1073\/pnas.1606996113.","DOI":"10.1073\/pnas.1606996113"},{"key":"10.1016\/j.intimp.2023.109945_b0250","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1016\/S0140-6736(21)00184-7","article-title":"Therapeutics targeting the IL-23 and IL-17 pathway in psoriasis","volume":"397","author":"Ghoreschi","year":"2021","journal-title":"Lancet (London, England)."},{"key":"10.1016\/j.intimp.2023.109945_b0255","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1111\/exd.12487","article-title":"Cellular sources of IL-17 in psoriasis: a paradigm shift?","volume":"23","author":"Keijsers","year":"2014","journal-title":"Exp. Dermatol."},{"key":"10.1016\/j.intimp.2023.109945_b0260","doi-asserted-by":"crossref","DOI":"10.3390\/ijms21041275","article-title":"Interleukin-17A and Keratinocytes in Psoriasis","volume":"21","author":"Furue","year":"2020","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.intimp.2023.109945_b0265","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s40204-021-00154-7","article-title":"Polymers in topical delivery of anti-psoriatic medications and other topical agents in overcoming the barriers of conventional treatment strategies","volume":"10","author":"Yadav","year":"2021","journal-title":"Prog. Biomater."},{"key":"10.1016\/j.intimp.2023.109945_b0270","doi-asserted-by":"crossref","first-page":"1664","DOI":"10.1172\/JCI200422147","article-title":"Recent insights into the immunopathogenesis of psoriasis provide new therapeutic opportunities","volume":"113","author":"Nickoloff","year":"2004","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.intimp.2023.109945_b0275","series-title":"Plants Phytomolecules Immunomodulation Recent Trends Adv","first-page":"1","article-title":"Immune System and Mechanism of Immunomodulation","author":"Singh","year":"2022"},{"key":"10.1016\/j.intimp.2023.109945_b0280","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejps.2020.105469","article-title":"Localised and sustained intradermal delivery of methotrexate using nanocrystal-loaded microneedle arrays: Potential for enhanced treatment of psoriasis","volume":"152","author":"Tekko","year":"2020","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.intimp.2023.109945_b0285","doi-asserted-by":"crossref","unstructured":"C. Karamani, I.T. Antoniadou, A. Dimou, E. Andreou, G. Kostakis, A. Sideri, A. Vitsos, A. Gkavanozi, I. Sfiniadakis, H. Skaltsa, G.T. Papaioannou, M.C. Rallis, H. Maibach, Optimization of psoriasis mouse models., J. Pharmacol. Toxicol. Methods. 108 (2021) 107054. https:\/\/doi.org\/10.1016\/j.vascn.2021.107054.","DOI":"10.1016\/j.vascn.2021.107054"},{"key":"10.1016\/j.intimp.2023.109945_b0290","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1111\/j.1742-7843.2006.pto_298.x","article-title":"In vivo pharmacological disease models for psoriasis and atopic dermatitis in drug discovery","volume":"99","author":"Petersen","year":"2006","journal-title":"Basic Clin. Paharmacol. Toxicol."},{"key":"10.1016\/j.intimp.2023.109945_b0295","doi-asserted-by":"crossref","unstructured":"M. Yokogawa, M. Takaishi, K. Nakajima, R. Kamijima, C. Fujimoto, S. Kataoka, Y. Terada, S. Sano, Epicutaneous application of toll-like receptor 7 agonists leads to systemic autoimmunity in wild-type mice: a new model of systemic Lupus erythematosus., Arthritis Rheumatol. (Hoboken, N.J.). 66 (2014) 694\u2013706. https:\/\/doi.org\/10.1002\/art.38298.","DOI":"10.1002\/art.38298"},{"key":"10.1016\/j.intimp.2023.109945_b0300","doi-asserted-by":"crossref","first-page":"10","DOI":"10.52228\/JRUB.2018-31-1-2","article-title":"Promising Phytoactives Candidates for Efficacious Treatment of Psoriasis and Other Skin Disorders","volume":"31","author":"Yadav","year":"2018","journal-title":"J. Ravishankar (Univ. (Part-B; Sci.)"},{"key":"10.1016\/j.intimp.2023.109945_b0305","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1038\/cmi.2010.30","article-title":"The TLR7 agonists imiquimod and gardiquimod improve DC-based immunotherapy for melanoma in mice","volume":"7","author":"Ma","year":"2010","journal-title":"Cell. Mol. Immunol."},{"key":"10.1016\/j.intimp.2023.109945_b0310","unstructured":"M.R. Singh, D. Singh, K.K. Sahu, M. Pradhan Krishna, Yadav, A method of preparation of Triamcinolone Acetonide encapsulated nanostructured lipid carriers for psoriasis treatment., (2021)."},{"key":"10.1016\/j.intimp.2023.109945_b0315","doi-asserted-by":"crossref","first-page":"579","DOI":"10.5958\/0974-360X.2019.00103.3","article-title":"Ajazuddin, Development and validation of a robust RP-HPLC method for analysis of calcipotriol in pharmaceutical dosage form","volume":"12","author":"Pradhan","year":"2019","journal-title":"Res. J. Pharm. Technol."},{"key":"10.1016\/j.intimp.2023.109945_b0320","doi-asserted-by":"crossref","DOI":"10.1016\/j.mehy.2020.110322","article-title":"Multifaceted targeting of cationic liposomes via co-delivery of anti-IL-17 siRNA and corticosteroid for topical treatment of psoriasis","volume":"145","author":"Yadav","year":"2020","journal-title":"Med. Hypotheses"},{"key":"10.1016\/j.intimp.2023.109945_b0325","doi-asserted-by":"crossref","DOI":"10.3390\/ijms18122514","article-title":"Models in the Research Process of Psoriasis","volume":"18","author":"Boche\u0144ska","year":"2017","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.intimp.2023.109945_b0330","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2021.174254","article-title":"Novel archetype in psoriasis management bridging molecular dynamics in exploring novel therapies","volume":"907","author":"Yadav","year":"2021","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.intimp.2023.109945_b0335","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1038\/s41419-021-04284-5","article-title":"Inhibition of keratinocyte ferroptosis suppresses psoriatic inflammation","volume":"12","author":"Shou","year":"2021","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.intimp.2023.109945_b0340","article-title":"Dermal nanomedicine: Uncovering the ability of nucleic acid to alleviate autoimmune and other related skin disorders","volume":"73","author":"Yadav","year":"2022","journal-title":"J. Drug Deliv. Sci. Technol."},{"key":"10.1016\/j.intimp.2023.109945_b0345","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1007\/s00281-015-0539-8","article-title":"Update on psoriasis immunopathogenesis and targeted immunotherapy","volume":"38","author":"Mahil","year":"2016","journal-title":"Semin. Immunopathol."},{"key":"10.1016\/j.intimp.2023.109945_b0350","doi-asserted-by":"crossref","first-page":"1158","DOI":"10.1177\/1535370217710637","article-title":"In vitro psoriasis models with focus on reconstructed skin models as promising tools in psoriasis research","volume":"242","author":"Desmet","year":"2017","journal-title":"Exp. Biol. Med. (Maywood)"},{"key":"10.1016\/j.intimp.2023.109945_b0355","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.jdermsci.2008.07.009","article-title":"Development of an in vitro psoriatic skin model by tissue engineering","volume":"53","author":"Jean","year":"2009","journal-title":"J. Dermatol. Sci."},{"key":"10.1016\/j.intimp.2023.109945_b0360","doi-asserted-by":"crossref","DOI":"10.3389\/fbioe.2022.803218","article-title":"In Vitro Disease Models for Understanding Psoriasis and Atopic Dermatitis","volume":"10","author":"Sarama","year":"2022","journal-title":"Front. Bioeng. Biotechnol."},{"key":"10.1016\/j.intimp.2023.109945_b0365","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.jdermsci.2019.12.010","article-title":"Ex vivo culture of lesional psoriasis skin for pharmacological testing","volume":"97","author":"Tiirikainen","year":"2020","journal-title":"J. Dermatol. Sci."},{"key":"10.1016\/j.intimp.2023.109945_b0370","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1080\/08982104.2019.1593449","article-title":"Preparation, characterization, and in vivo evaluation of cyclosporine cationic liposomes for the treatment of psoriasis","volume":"30","author":"Walunj","year":"2020","journal-title":"J. Liposome Res."},{"key":"10.1016\/j.intimp.2023.109945_b0375","doi-asserted-by":"crossref","first-page":"e4375","DOI":"10.21769\/BioProtoc.4375","article-title":"Ex-vivo Skin Permeability Tests of Nanoparticles for Microscopy Imaging","volume":"12","author":"Friedman","year":"2022","journal-title":"Bio-Protocol."},{"key":"10.1016\/j.intimp.2023.109945_b0380","doi-asserted-by":"crossref","first-page":"3112","DOI":"10.2353\/ajpath.2010.100078","article-title":"Development of a Bioengineered Skin-Humanized Mouse Model for Psoriasis: Dissecting Epidermal-Lymphocyte Interacting Pathways","volume":"177","author":"Guerrero-Aspizua","year":"2010","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.intimp.2023.109945_b0385","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1007\/978-1-4939-6786-5_7","article-title":"Xenotransplantation Model of Psoriasis","volume":"1559","author":"Di Domizio","year":"2017","journal-title":"Methods Mol. Biol."},{"key":"10.1016\/j.intimp.2023.109945_b0390","doi-asserted-by":"crossref","DOI":"10.1016\/j.vascn.2019.106657","article-title":"Murine models of psoriasis and its applications in drug development","volume":"101","author":"Luo","year":"2020","journal-title":"J. Pharmacol. Toxicol. Methods"},{"key":"10.1016\/j.intimp.2023.109945_b0395","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1046\/j.1365-2133.2001.04178.x","article-title":"Severe combined immunodeficiency mouse-human skin chimeras: a unique animal model for the study of psoriasis and cutaneous inflammation","volume":"144","author":"Raychaudhuri","year":"2001","journal-title":"Br. J. Dermatol."},{"key":"10.1016\/j.intimp.2023.109945_b0400","doi-asserted-by":"crossref","unstructured":"S. Sidgiddi, S.M.H. Naqvi, M. Shenoy, D.N. Balraj, J. Kothari, S. Gupta, R. Haq, R. Mittal, S. Mehta, A. Mane, Efficacy and Safety of Novel Formulation of Clobetasol Propionate 0.025% Cream in Indian Moderate-to-Severe Psoriasis Patients: Phase-2a, Randomized 3-Arm Study., Dermatol. Ther. (Heidelb). 11 (2021) 1717\u20131732. https:\/\/doi.org\/10.1007\/s13555-021-00591-z.","DOI":"10.1007\/s13555-021-00591-z"},{"key":"10.1016\/j.intimp.2023.109945_b0405","doi-asserted-by":"crossref","first-page":"938","DOI":"10.1124\/jpet.107.130955","article-title":"7-Chloro-5-(4-hydroxyphenyl)-1-methyl-3-(naphthalen-2-ylmethyl)-4,5-dihydro-1H-benzo[b][1,4]diazepin-2(3H)-one (Bz-423), a benzodiazepine, suppresses keratinocyte proliferation and has antipsoriatic activity in the human skin-severe, combined immunodefic","volume":"324","author":"Bhagavathula","year":"2008","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.intimp.2023.109945_b0410","doi-asserted-by":"crossref","first-page":"884","DOI":"10.1016\/j.jid.2021.06.019","article-title":"Mouse Models of Psoriasis: A Comprehensive Review","volume":"142","author":"Gangwar","year":"2022","journal-title":"J, Invest. Dermatol."},{"key":"10.1016\/j.intimp.2023.109945_b0415","doi-asserted-by":"crossref","first-page":"980","DOI":"10.1159\/000430272","article-title":"Ginsenoside Rh2 Suppresses Neovascularization in Xenograft Psoriasis Model","volume":"36","author":"Zhou","year":"2015","journal-title":"Cell. Physiol. Biochem. Int. J. Exp. Cell. Physiol. Biochem. Pharmacol."},{"key":"10.1016\/j.intimp.2023.109945_b0420","doi-asserted-by":"crossref","first-page":"61ra90","DOI":"10.1126\/scitranslmed.3001108","article-title":"Gene from a psoriasis susceptibility locus primes the skin for inflammation","volume":"2","author":"Wolf","year":"2010","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.intimp.2023.109945_b0425","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1038\/s41419-022-04523-3","article-title":"Advances in the pathogenesis of psoriasis: from keratinocyte perspective","volume":"13","author":"Zhou","year":"2022","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.intimp.2023.109945_b0430","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.618581","article-title":"The Role of the IL-23\/IL-17 Axis in Disease Initiation in Spondyloarthritis: Lessons Learned From Animal Models","volume":"12","author":"Mandour","year":"2021","journal-title":"Front. Immunol."},{"key":"10.1016\/j.intimp.2023.109945_b0435","doi-asserted-by":"crossref","first-page":"2795","DOI":"10.1038\/jid.2009.173","article-title":"Global gene expression analysis reveals evidence for decreased lipid biosynthesis and increased innate immunity in uninvolved psoriatic skin","volume":"129","author":"Gudjonsson","year":"2009","journal-title":"J, Invest. Dermatol."},{"key":"10.1016\/j.intimp.2023.109945_b0440","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/j.jdermsci.2010.03.023","article-title":"Vascular endothelial growth factor (VEGF) in the pathogenesis of psoriasis\u2014A possible target for novel therapies?","volume":"58","author":"Canavese","year":"2010","journal-title":"J. Dermatol. Sci."},{"key":"10.1016\/j.intimp.2023.109945_b0445","doi-asserted-by":"crossref","DOI":"10.3389\/fmed.2021.630237","article-title":"Comparative Study on Different Skin Pruritus Mouse Models","volume":"8","author":"Donglang","year":"2021","journal-title":"Front. Med."},{"key":"10.1016\/j.intimp.2023.109945_b0450","doi-asserted-by":"crossref","first-page":"e0145498","DOI":"10.1371\/journal.pone.0145498","article-title":"IMQ Induced K14-VEGF Mouse: A Stable and Long-Term Mouse Model of Psoriasis-Like Inflammation","volume":"10","author":"Wang","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.intimp.2023.109945_b0455","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1684\/ejd.2022.4230","article-title":"Calcipotriol inhibits psoriasis-like angiogenic features in K14-VEGF transgenic mice","volume":"32","author":"Cao","year":"2022","journal-title":"Eur. J. Dermatology."},{"key":"10.1016\/j.intimp.2023.109945_b0460","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1111\/j.1365-2133.2010.10129.x","article-title":"Depletion of antigen-presenting cells by clodronate liposomes reverses the psoriatic skin phenotype in KC-Tie2 mice","volume":"164","author":"Ward","year":"2011","journal-title":"Br. J. Dermatol."},{"key":"10.1016\/j.intimp.2023.109945_b0465","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.151911","article-title":"Phospholipase A2 enzymes represent a shared pathogenic pathway in psoriasis and pityriasis rubra pilaris","volume":"6","author":"Shao","year":"2021","journal-title":"JCI Insight"},{"key":"10.1016\/j.intimp.2023.109945_b0470","doi-asserted-by":"crossref","first-page":"1901","DOI":"10.1084\/jem.20141904","article-title":"The role of group IIF-secreted phospholipase A2 in epidermal homeostasis and hyperplasia","volume":"212","author":"Yamamoto","year":"2015","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.intimp.2023.109945_b0475","doi-asserted-by":"crossref","DOI":"10.1084\/jem.20191397","article-title":"Interleukin-17 cytokines: Effectors and targets in psoriasis-A breakthrough in understanding and treatment","volume":"217","author":"Prinz","year":"2020","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.intimp.2023.109945_b0480","doi-asserted-by":"crossref","first-page":"17023-","DOI":"10.1038\/sigtrans.2017.23","article-title":"NF-\u03baB signaling in inflammation","volume":"2","author":"Liu","year":"2017","journal-title":"Signal Transduct Target. Ther."},{"key":"10.1016\/j.intimp.2023.109945_b0485","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.130835","article-title":"Keratinocyte-derived I\u03baB\u03b6 drives psoriasis and associated systemic inflammation","volume":"4","author":"Lorscheid","year":"2019","journal-title":"JCI Insight"},{"key":"10.1016\/j.intimp.2023.109945_b0490","doi-asserted-by":"crossref","first-page":"1617","DOI":"10.4049\/jimmunol.182.3.1617","article-title":"The adaptor protein CIKS\/Act1 is essential for IL-25-mediated allergic airway inflammation","volume":"182","author":"Claudio","year":"2009","journal-title":"J. Immunol."},{"key":"10.1016\/j.intimp.2023.109945_b0495","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.56720","article-title":"CARD14(E138A) signalling in keratinocytes induces TNF-dependent skin and systemic inflammation","volume":"9","author":"Manils","year":"2020","journal-title":"Elife"},{"key":"10.1016\/j.intimp.2023.109945_b0500","doi-asserted-by":"crossref","unstructured":"D. Kluwig, S. Huth, A.T. Abdallah, C.M. Pfaff, K. Fietkau, L. Huth, Y. Marquardt, J.M. Baron, B. L\u00fcscher, Establishment of an Intradermal Ear Injection Model of IL-17A and IL-36\u03b3 as a Tool to Investigate the Psoriatic Cytokine Network., Life (Basel, Switzerland). 11 (2021). https:\/\/doi.org\/10.3390\/life11080846.","DOI":"10.3390\/life11080846"},{"key":"10.1016\/j.intimp.2023.109945_b0505","doi-asserted-by":"crossref","first-page":"15395","DOI":"10.1038\/ncomms15395","article-title":"TWEAK mediates inflammation in experimental atopic dermatitis and psoriasis","volume":"8","author":"Sidler","year":"2017","journal-title":"Nat. Commun."},{"key":"10.1016\/j.intimp.2023.109945_b0510","doi-asserted-by":"crossref","first-page":"2106","DOI":"10.1038\/s41598-021-81588-8","article-title":"Suppression of IL-23-mediated psoriasis-like inflammation by regulatory B cells","volume":"11","author":"Mizumaki","year":"2021","journal-title":"Sci. Rep."},{"key":"10.1016\/j.intimp.2023.109945_b0515","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1007\/s12016-018-8702-3","article-title":"The Immunologic Role of IL-17 in Psoriasis and Psoriatic Arthritis Pathogenesis","volume":"55","author":"Blauvelt","year":"2018","journal-title":"Clin. Rev. Allergy Immunol."},{"key":"10.1016\/j.intimp.2023.109945_b0520","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1186\/s13073-017-0415-3","article-title":"Imiquimod has strain-dependent effects in mice and does not uniquely model human psoriasis","volume":"9","author":"Swindell","year":"2017","journal-title":"Genome Med."},{"key":"10.1016\/j.intimp.2023.109945_b0525","doi-asserted-by":"crossref","first-page":"1307","DOI":"10.1016\/j.molimm.2004.01.002","article-title":"Imiquimod, a Toll-like receptor-7 agonist, induces perforin in cytotoxic T lymphocytes in vitro","volume":"40","author":"Ambach","year":"2004","journal-title":"Mol. Immunol."},{"key":"10.1016\/j.intimp.2023.109945_b0530","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1189\/jlb.3MA0217-054RR","article-title":"Role of MyD88 signaling in the imiquimod-induced mouse model of psoriasis: focus on innate myeloid cells","volume":"102","author":"Costa","year":"2017","journal-title":"J. Leukoc. Biol."},{"key":"10.1016\/j.intimp.2023.109945_b0535","doi-asserted-by":"crossref","first-page":"1796","DOI":"10.1016\/j.ijbiomac.2018.07.021","article-title":"Protein biomarker for psoriasis: A systematic review on their role in the pathomechanism, diagnosis, potential targets and treatment of psoriasis","volume":"118","author":"Yadav","year":"2018","journal-title":"Int. J. Biol. Macromol."},{"key":"10.1016\/j.intimp.2023.109945_b0540","doi-asserted-by":"crossref","first-page":"E3422","DOI":"10.1073\/pnas.1400513111","article-title":"IL-17 drives psoriatic inflammation via distinct, target cell-specific mechanisms","volume":"111","author":"Ha","year":"2014","journal-title":"PNAS"},{"key":"10.1016\/j.intimp.2023.109945_b0545","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1038\/jid.2012.318","article-title":"An Alternative Pathway of Imiquimod-Induced Psoriasis-Like Skin Inflammation in the Absence of Interleukin-17 Receptor A Signaling","volume":"133","author":"El Malki","year":"2013","journal-title":"J, Invest. Dermatol."},{"key":"10.1016\/j.intimp.2023.109945_b0550","article-title":"Exacerbated Imiquimod-Induced Psoriasis-Like Skin Inflammation in IRF5-Deficient Mice","volume":"21","author":"Nakao","year":"2020","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.intimp.2023.109945_b0555","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1016\/j.jid.2016.10.024","article-title":"The Snowballing Literature on Imiquimod-Induced Skin Inflammation in Mice: A Critical Appraisal","volume":"137","author":"Hawkes","year":"2017","journal-title":"J, Invest. Dermatol."},{"key":"10.1016\/j.intimp.2023.109945_b0560","article-title":"JNK1 Signaling Downstream of the EGFR Pathway Contributes to Aldara(\u00ae)-Induced Skin Inflammation","volume":"11","author":"Le","year":"2020","journal-title":"Front. Immunol."},{"key":"10.1016\/j.intimp.2023.109945_b0565","doi-asserted-by":"crossref","first-page":"e0137890","DOI":"10.1371\/journal.pone.0137890","article-title":"Using Imiquimod-Induced Psoriasis-Like Skin as a Model to Measure the Skin Penetration of Anti-Psoriatic Drugs","volume":"10","author":"Lin","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.intimp.2023.109945_b0570","doi-asserted-by":"crossref","first-page":"3138","DOI":"10.1002\/eji.201343801","article-title":"TLRs to cytokines: mechanistic insights from the imiquimod mouse model of psoriasis","volume":"43","author":"Flutter","year":"2013","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.intimp.2023.109945_b0575","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1111\/j.1440-0960.2004.00030.x","article-title":"Psoriasis induced by topical imiquimod","volume":"45","author":"Wu","year":"2004","journal-title":"Australas. J. Dermatol."},{"key":"10.1016\/j.intimp.2023.109945_b0580","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1093\/protein\/gzv034","article-title":"AZ17: a new bispecific drug targeting IL-6 and IL-23 with potential clinical use\u2013improves psoriasis in a human xenograft transplantation model","volume":"28","author":"Stenderup","year":"2015","journal-title":"Protein Eng. Des. Sel."},{"key":"10.1016\/j.intimp.2023.109945_b0585","first-page":"255","article-title":"The Expanding Role of Anti-IL-12 and\/or Anti-IL-23 Antibodies in the Treatment of Inflammatory Bowel Disease","volume":"15","author":"Kashani","year":"2019","journal-title":"Gastroenterol. Hepatol. (N. Y)."},{"key":"10.1016\/j.intimp.2023.109945_b0590","doi-asserted-by":"crossref","first-page":"966","DOI":"10.5958\/0974-360X.2021.00172.4","article-title":"Development and characterization of corticosteroid loaded lipid carrier system for psoriasis","volume":"14","author":"Yadav","year":"2021","journal-title":"Res. J. Pharm. Technol."},{"key":"10.1016\/j.intimp.2023.109945_b0595","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics14030682","article-title":"Skin-on-a-Chip Technology: Microengineering Physiologically Relevant In Vitro Skin Models","volume":"14","author":"Zoio","year":"2022","journal-title":"Pharmaceutics."},{"key":"10.1016\/j.intimp.2023.109945_b0600","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1002\/jcla.21717","article-title":"Serum vascular endothelial growth factor, transforming growth factor \u03b21, and nitric oxide levels in patients with psoriasis vulgaris: their correlation to disease severity","volume":"28","author":"Meki","year":"2014","journal-title":"J. Clin. Lab. Anal."},{"key":"10.1016\/j.intimp.2023.109945_b0605","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1111\/j.1365-2613.2009.00669.x","article-title":"Angiogenesis drives psoriasis pathogenesis","volume":"90","author":"Heidenreich","year":"2009","journal-title":"Int. J. Exp. Pathol."},{"key":"10.1016\/j.intimp.2023.109945_b0610","doi-asserted-by":"crossref","first-page":"21","DOI":"10.3233\/JCB-179004","article-title":"In vitro skin three-dimensional models and their applications","volume":"3","author":"Klicks","year":"2017","journal-title":"J. Cell. Biotechnol."},{"key":"10.1016\/j.intimp.2023.109945_b0615","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1016\/j.bbrep.2016.09.012","article-title":"A 3D-psoriatic skin model for dermatological testing: The impact of culture conditions","volume":"8","author":"Duque-Fernandez","year":"2016","journal-title":"Biochem. Biophys. Reports."},{"key":"10.1016\/j.intimp.2023.109945_b0620","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1098\/rsif.2009.0403","article-title":"A review of tissue-engineered skin bioconstructs available for skin reconstruction","volume":"7","author":"Shevchenko","year":"2010","journal-title":"J. R. Soc. Interface"},{"key":"10.1016\/j.intimp.2023.109945_b0625","doi-asserted-by":"crossref","first-page":"28s","DOI":"10.1111\/1523-1747.ep12540324","article-title":"Methods for cultivation of keratinocytes with an air-liquid interface","volume":"81","author":"Pruni\u00e9ras","year":"1983","journal-title":"J, Invest. Dermatol."},{"key":"10.1016\/j.intimp.2023.109945_b0630","doi-asserted-by":"crossref","first-page":"e0224228","DOI":"10.1371\/journal.pone.0224228","article-title":"Linoleic acid supplementation of cell culture media influences the phospholipid and lipid profiles of human reconstructed adipose tissue","volume":"14","author":"Ouellette","year":"2019","journal-title":"PLoS One"},{"key":"10.1016\/j.intimp.2023.109945_b0635","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1038\/cmi.2012.15","article-title":"New insights of T cells in the pathogenesis of psoriasis","volume":"9","author":"Cai","year":"2012","journal-title":"Cell. Mol. Immunol."},{"key":"10.1016\/j.intimp.2023.109945_b0640","series-title":"5 - In vitro models of psoriasis","first-page":"103","author":"Roy","year":"2018"},{"key":"10.1016\/j.intimp.2023.109945_b0645","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1046\/j.1432-0436.1994.5810077.x","article-title":"Comparative analysis of normal and psoriatic skin both in vivo and in vitro","volume":"58","author":"Mils","year":"1994","journal-title":"Differentiation"},{"key":"10.1016\/j.intimp.2023.109945_b0650","doi-asserted-by":"crossref","first-page":"21192","DOI":"10.1038\/s41598-020-78292-4","article-title":"Human skin explant model for the investigation of topical therapeutics","volume":"10","author":"Neil","year":"2020","journal-title":"Sci. Rep."},{"key":"10.1016\/j.intimp.2023.109945_b0655","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1016\/j.tig.2010.06.006","article-title":"Psoriasis genetics: breaking the barrier","volume":"26","author":"Roberson","year":"2010","journal-title":"Trends Genet."},{"key":"10.1016\/j.intimp.2023.109945_b0660","doi-asserted-by":"crossref","first-page":"4123","DOI":"10.1038\/s41598-020-60275-0","article-title":"Recapitulating T cell infiltration in 3D psoriatic skin models for patient-specific drug testing","volume":"10","author":"Shin","year":"2020","journal-title":"Sci. Rep."},{"key":"10.1016\/j.intimp.2023.109945_b0665","doi-asserted-by":"crossref","first-page":"815","DOI":"10.2353\/ajpath.2008.080173","article-title":"Development and validation of human psoriatic skin equivalents","volume":"173","author":"Tjabringa","year":"2008","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.intimp.2023.109945_b0670","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1038\/jid.2013.417","article-title":"Crosstalk between keratinocytes and T cells in a 3D microenvironment: a model to study inflammatory skin diseases","volume":"134","author":"van den Bogaard","year":"2014","journal-title":"J, Invest. Dermatol."},{"key":"10.1016\/j.intimp.2023.109945_b0675","doi-asserted-by":"crossref","first-page":"e284","DOI":"10.1097\/GOX.0000000000000219","article-title":"Dermal matrices and bioengineered skin substitutes: a critical review of current options","volume":"3","author":"Debels","year":"2015","journal-title":"Plast. Reconstr. Surgery. Glob. Open."},{"key":"10.1016\/j.intimp.2023.109945_b0680","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1203\/PDR.0b013e31816c5bc3","article-title":"Collagen tissue engineering: development of novel biomaterials and applications","volume":"63","author":"Cen","year":"2008","journal-title":"Pediatr. Res."},{"key":"10.1016\/j.intimp.2023.109945_b0685","doi-asserted-by":"crossref","first-page":"154","DOI":"10.3389\/fbioe.2018.00154","article-title":"Advances in the Biofabrication of 3D Skin in vitro: Healthy and Pathological Models","volume":"6","author":"Randall","year":"2018","journal-title":"Front. Bioeng. Biotechnol."},{"key":"10.1016\/j.intimp.2023.109945_b0690","doi-asserted-by":"crossref","DOI":"10.3791\/62125","article-title":"Generation of Self-assembled Vascularized Human Skin Equivalents","author":"Sanchez","year":"2021","journal-title":"J. Vis. Exp."},{"key":"10.1016\/j.intimp.2023.109945_b0695","doi-asserted-by":"crossref","DOI":"10.3390\/ijms21134644","article-title":"A Simple Method for the Production of Human Skin Equivalent in 3D, Multi-Cell Culture","volume":"21","author":"Szyma\u0144ski","year":"2020","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.intimp.2023.109945_b0700","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1126\/science.2413549","article-title":"Psoriatic fibroblasts induce hyperproliferation of normal keratinocytes in a skin equivalent model in vitro","volume":"230","author":"Saiag","year":"1985","journal-title":"Science"},{"key":"10.1016\/j.intimp.2023.109945_b0705","doi-asserted-by":"crossref","DOI":"10.3390\/polym13223868","article-title":"A Review of the Effects of Collagen Treatment in Clinical Studies","volume":"13","author":"Wang","year":"2021","journal-title":"Polymers (Basel)"},{"key":"10.1016\/j.intimp.2023.109945_b0710","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1111\/1523-1747.ep12584215","article-title":"Interleukin-8 is induced in skin equivalents and is highest in those derived from psoriatic fibroblasts","volume":"107","author":"Konstantinova","year":"1996","journal-title":"J, Invest. Dermatol."},{"key":"10.1016\/j.intimp.2023.109945_b0715","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1111\/j.0022-202X.2004.23435.x","article-title":"The development and characterization of an in vitro model of psoriasis","volume":"123","author":"Barker","year":"2004","journal-title":"J, Invest. Dermatol."},{"key":"10.1016\/j.intimp.2023.109945_b0720","doi-asserted-by":"crossref","first-page":"1785","DOI":"10.1038\/jid.2010.103","article-title":"Psoriasis and Systemic Inflammatory Diseases: Potential Mechanistic Links between Skin Disease and Co-Morbid Conditions","volume":"130","author":"Davidovici","year":"2010","journal-title":"J, Invest. Dermatol."},{"key":"10.1016\/j.intimp.2023.109945_b0725","doi-asserted-by":"crossref","DOI":"10.3390\/ijms20071670","article-title":"Infiltration of T Cells into a Three-Dimensional Psoriatic Skin Model Mimics Pathological Key Features","volume":"20","author":"Lorthois","year":"2019","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.intimp.2023.109945_b0730","article-title":"A Narrative Review of the History of Skin Grafting in Burn Care","volume":"57","author":"Ozhathil","year":"2021","journal-title":"Medicina (Kaunas)"},{"key":"10.1016\/j.intimp.2023.109945_b0735","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1007\/s11626-999-0081-x","article-title":"Characterization of a new tissue-engineered human skin equivalent with hair","volume":"35","author":"Michel","year":"1999","journal-title":"In Vitro Cell. Dev. Biol. Anim."},{"key":"10.1016\/j.intimp.2023.109945_b0740","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1111\/j.1365-3164.2012.01097.x","article-title":"Epidermal structure created by canine hair follicle keratinocytes enriched with bulge cells in a three-dimensional skin equivalent model in vitro: implications for regenerative therapy of canine epidermis","volume":"24","author":"Kobayashi","year":"2013","journal-title":"Vet. Dermatol."},{"key":"10.1016\/j.intimp.2023.109945_b0745","first-page":"35","article-title":"Cellular human tissue-engineered skin substitutes investigated for deep and difficult to heal injuries., NPJ","volume":"6","author":"Sierra-S\u00e1nchez","year":"2021","journal-title":"Regen. Med."},{"key":"10.1016\/j.intimp.2023.109945_b0750","doi-asserted-by":"crossref","first-page":"2448","DOI":"10.1089\/ten.tea.2015.0139","article-title":"Development of a Full-Thickness Human Skin Equivalent In Vitro Model Derived from TERT-Immortalized Keratinocytes and Fibroblasts","volume":"21","author":"Reijnders","year":"2015","journal-title":"Tissue Eng. A"},{"key":"10.1016\/j.intimp.2023.109945_b0755","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1590\/S1519-69842007000100014","article-title":"Thermolysin in human cultured keratinocyte isolation","volume":"67","author":"Gragnani","year":"2007","journal-title":"Braz. J. Biol."},{"key":"10.1016\/j.intimp.2023.109945_b0760","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/0305-4179(93)90028-7","article-title":"Improvement of human keratinocyte isolation and culture using thermolysin","volume":"19","author":"Germain","year":"1993","journal-title":"Burns"},{"key":"10.1016\/j.intimp.2023.109945_b0765","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.exer.2016.09.008","article-title":"An important role for adenine, cholera toxin, hydrocortisone and triiodothyronine in the proliferation, self-renewal and differentiation of limbal stem cells in vitro","volume":"152","author":"Yu","year":"2016","journal-title":"Exp. Eye Res."},{"key":"10.1016\/j.intimp.2023.109945_b0770","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.actbio.2018.09.030","article-title":"Directing fibroblast self-assembly to fabricate highly-aligned, collagen-rich matrices","volume":"81","author":"Wilks","year":"2018","journal-title":"Acta Biomater."},{"key":"10.1016\/j.intimp.2023.109945_b0775","doi-asserted-by":"crossref","unstructured":"A. Grenier, Optimization of the Self-Assembly Method for the Production of Psoriatic Skin Substitutes, in: I. Gendreau (Ed.), IntechOpen, Rijeka, 2018: p. Ch. 10. https:\/\/doi.org\/10.5772\/intechopen.79843.","DOI":"10.5772\/intechopen.79843"},{"key":"10.1016\/j.intimp.2023.109945_b0780","doi-asserted-by":"crossref","unstructured":"Y.C. Boo, Ascorbic Acid (Vitamin C) as a Cosmeceutical to Increase Dermal Collagen for Skin Antiaging Purposes: Emerging Combination Therapies., Antioxidants (Basel, Switzerland). 11 (2022). https:\/\/doi.org\/10.3390\/antiox11091663.","DOI":"10.3390\/antiox11091663"},{"key":"10.1016\/j.intimp.2023.109945_b0785","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics14061211","article-title":"Structural and Functional Validation of a Full-Thickness Self-Assembled Skin Equivalent for Disease Modeling","volume":"14","author":"Mok","year":"2022","journal-title":"Pharmaceutics."},{"key":"10.1016\/j.intimp.2023.109945_b0790","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1007\/s11626-020-00517-7","article-title":"Invited review: human air-liquid-interface organotypic airway tissue models derived from primary tracheobronchial epithelial cells-overview and perspectives","volume":"57","author":"Cao","year":"2021","journal-title":"In Vitro Cell. Dev. Biol. Anim."},{"key":"10.1016\/j.intimp.2023.109945_b0795","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1111\/1523-1747.ep12393187","article-title":"Effects of ascorbic acid on proliferation and collagen synthesis in relation to the donor age of human dermal fibroblasts","volume":"103","author":"Phillips","year":"1994","journal-title":"J, Invest. Dermatol."},{"key":"10.1016\/j.intimp.2023.109945_b0800","doi-asserted-by":"crossref","first-page":"74","DOI":"10.3389\/fbioe.2019.00074","article-title":"Heparin-Modified Collagen Gels for Controlled Release of Pleiotrophin: Potential for Vascular Applications","volume":"7","author":"Copes","year":"2019","journal-title":"Front. Bioeng Biotechnol."},{"key":"10.1016\/j.intimp.2023.109945_b0805","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1146\/annurev-immunol-032713-120225","article-title":"Immunology of psoriasis","volume":"32","author":"Lowes","year":"2014","journal-title":"Annu. Rev. Immunol."},{"key":"10.1016\/j.intimp.2023.109945_b0810","doi-asserted-by":"crossref","unstructured":"H.C. Hennies, Y. Poumay, Skin Disease Models In Vitro and Inflammatory Mechanisms: Predictability for Drug Development BT - Organotypic Models in Drug Development, in: M. Sch\u00e4fer-Korting, S. Stuchi Maria-Engler, R. Landsiedel (Eds.), Springer International Publishing, Cham, 2021: pp. 187\u2013218. https:\/\/doi.org\/10.1007\/164_2020_428.","DOI":"10.1007\/164_2020_428"},{"key":"10.1016\/j.intimp.2023.109945_b0815","doi-asserted-by":"crossref","unstructured":"P. B\u00e9dard, S. Gauvin, K. Ferland, C. Caneparo, \u00c8. Pellerin, S. Chabaud, S. Bolduc, Innovative Human Three-Dimensional Tissue-Engineered Models as an Alternative to Animal Testing., Bioeng. (Basel, Switzerland). 7 (2020). https:\/\/doi.org\/10.3390\/bioengineering7030115.","DOI":"10.3390\/bioengineering7030115"},{"key":"10.1016\/j.intimp.2023.109945_b0820","article-title":"Perspective: Extending the Utility of Three-Dimensional Organoids by Tissue Clearing Technologies., Front. Cell","volume":"9","author":"Susaki","year":"2021","journal-title":"Dev. Biol."},{"key":"10.1016\/j.intimp.2023.109945_b0825","doi-asserted-by":"crossref","first-page":"1715","DOI":"10.1182\/blood-2010-01-263509","article-title":"Human fibroblasts support the expansion of IL-17-producing T cells via up-regulation of IL-23 production by dendritic cells","volume":"116","author":"Schirmer","year":"2010","journal-title":"Blood"},{"key":"10.1016\/j.intimp.2023.109945_b0830","doi-asserted-by":"crossref","first-page":"1225","DOI":"10.1111\/j.0022-202X.2005.23715.x","article-title":"Human keratinocytes respond to interleukin-18: implication for the course of chronic inflammatory skin diseases","volume":"124","author":"Wittmann","year":"2005","journal-title":"J, Invest. Dermatol."},{"key":"10.1016\/j.intimp.2023.109945_b0835","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1038\/s41423-019-0261-x","article-title":"Keratinocytes costimulate naive human T cells via CD2: a potential target to prevent the development of proinflammatory Th1 cells in the skin","volume":"17","author":"Orlik","year":"2020","journal-title":"Cell. Mol. Immunol."},{"key":"10.1016\/j.intimp.2023.109945_b0840","doi-asserted-by":"crossref","DOI":"10.3390\/ijms20236008","article-title":"Cytokines in Inflammatory Disease","volume":"20","author":"Kany","year":"2019","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.intimp.2023.109945_b0845","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.801579","article-title":"Cytokine-Mediated Crosstalk Between Keratinocytes and T Cells in Atopic Dermatitis","volume":"13","author":"Humeau","year":"2022","journal-title":"Front. Immunol."},{"key":"10.1016\/j.intimp.2023.109945_b0850","doi-asserted-by":"crossref","first-page":"2149","DOI":"10.3389\/fimmu.2020.02149","article-title":"CXCL4 Links Inflammation and Fibrosis by Reprogramming Monocyte-Derived Dendritic Cells in vitro","volume":"11","author":"Silva-Cardoso","year":"2020","journal-title":"Front. Immunol."},{"key":"10.1016\/j.intimp.2023.109945_b0855","doi-asserted-by":"crossref","first-page":"536","DOI":"10.3389\/fimmu.2019.00536","article-title":"Defective Induction of COX-2 Expression by Psoriatic Fibroblasts Promotes Pro-inflammatory Activation of Macrophages","volume":"10","author":"Arasa","year":"2019","journal-title":"Front. Immunol."},{"key":"10.1016\/j.intimp.2023.109945_b0860","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1186\/s13063-021-05707-6","article-title":"Long-term improvement of psoriasis patients\u2019 adherence to topical drugs: testing a patient-supporting intervention delivered by healthcare professionals","volume":"22","author":"Svendsen","year":"2021","journal-title":"Trials"},{"key":"10.1016\/j.intimp.2023.109945_b0865","doi-asserted-by":"crossref","DOI":"10.3390\/biom11030371","article-title":"The Effect of Herbal Medicinal Products on Psoriasis-Like Keratinocytes","volume":"11","author":"Gendrisch","year":"2021","journal-title":"Biomolecules"},{"key":"10.1016\/j.intimp.2023.109945_b0870","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1080\/14789450.2016.1177462","article-title":"Lipidomic analysis of epidermal lipids: a tool to predict progression of inflammatory skin disease in humans","volume":"13","author":"Li","year":"2016","journal-title":"Expert Rev. Proteomics"},{"key":"10.1016\/j.intimp.2023.109945_b0875","first-page":"314","article-title":"Formation and functions of the corneocyte lipid envelope (CLE)","volume":"2014","author":"Elias","year":"1841","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.intimp.2023.109945_b0880","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics12020152","article-title":"Alternatives to Biological Skin in Permeation Studies: Current Trends and Possibilities","volume":"12","author":"Neupane","year":"2020","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.intimp.2023.109945_b0885","doi-asserted-by":"crossref","unstructured":"U. Radzikowska, A.O. Rinaldi, Z. \u00c7elebi S\u00f6zener, D. Karaguzel, M. Wojcik, K. Cypryk, M. Akdis, C.A. Akdis, M. Sokolowska, The Influence of Dietary Fatty Acids on Immune Responses., Nutrients. 11 (2019). https:\/\/doi.org\/10.3390\/nu11122990.","DOI":"10.3390\/nu11122990"},{"key":"10.1016\/j.intimp.2023.109945_b0890","first-page":"1110","article-title":"A review on angiogenesis and its assays","volume":"15","author":"Tahergorabi","year":"2012","journal-title":"Iran. J. Basic Med. Sci."},{"key":"10.1016\/j.intimp.2023.109945_b0895","doi-asserted-by":"crossref","DOI":"10.3390\/ijms23095226","article-title":"The Protective Role of pVHL in Imiquimod-Induced Psoriasis-like Skin Inflammation","volume":"23","author":"Mart\u00ednez-Torres","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.intimp.2023.109945_b0900","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.progpolymsci.2015.02.004","article-title":"Advancing biomaterials of human origin for tissue engineering","volume":"53","author":"Chen","year":"2016","journal-title":"Prog. Polym. Sci."},{"key":"10.1016\/j.intimp.2023.109945_b0905","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1098\/rsif.2006.0124","article-title":"Challenges in tissue engineering","volume":"3","author":"Ikada","year":"2006","journal-title":"J. R. Soc. Interface"},{"key":"10.1016\/j.intimp.2023.109945_b0910","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/j.ijpharm.2013.08.086","article-title":"Permeability and lipid organization of a novel psoriasis stratum corneum substitute","volume":"457","author":"Basse","year":"2013","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.intimp.2023.109945_b0915","doi-asserted-by":"crossref","first-page":"1266","DOI":"10.1002\/jps.2600821217","article-title":"Permeabilities of alkyl p-aminobenzoates through living skin equivalent and cadaver skin","volume":"82","author":"Roy","year":"1993","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.intimp.2023.109945_b0920","doi-asserted-by":"crossref","first-page":"1457","DOI":"10.1089\/ten.tea.2009.0090","article-title":"Normal human epithelial cells regulate the size and morphology of tissue-engineered capillaries","volume":"16","author":"Rochon","year":"2010","journal-title":"Tissue Eng. A"},{"key":"10.1016\/j.intimp.2023.109945_b0925","article-title":"In vitro construction of scaffold-free bilayered tissue-engineered skin containing capillary networks","volume":"2013","author":"Liu","year":"2013","journal-title":"Biomed Res Int."},{"key":"10.1016\/j.intimp.2023.109945_b0930","doi-asserted-by":"crossref","first-page":"9759735","DOI":"10.1155\/2017\/9759735","article-title":"Markers and Biomarkers of Endothelium: When Something Is Rotten in the State","volume":"2017","author":"Goncharov","year":"2017","journal-title":"Oxid. Med. Cell. Longev."},{"key":"10.1016\/j.intimp.2023.109945_b0935","article-title":"Behaviour of endothelial cells in a tridimensional in vitro environment., Biomed Res","volume":"2015","author":"Ayata","year":"2015","journal-title":"Int."},{"key":"10.1016\/j.intimp.2023.109945_b0940","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1186\/s12864-015-1508-2","article-title":"Transcriptional landscape of psoriasis identifies the involvement of IL36 and IL36RN","volume":"16","author":"Keermann","year":"2015","journal-title":"BMC Genomics"},{"key":"10.1016\/j.intimp.2023.109945_b0945","doi-asserted-by":"crossref","DOI":"10.3390\/genes11101155","article-title":"Transcriptome Profiling Analyses in Psoriasis: A Dynamic Contribution of Keratinocytes to the Pathogenesis","volume":"11","author":"Rioux","year":"2020","journal-title":"Genes (Basel)"},{"key":"10.1016\/j.intimp.2023.109945_b0950","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1038\/s41419-021-03724-6","article-title":"Single cell transcriptional zonation of human psoriasis skin identifies an alternative immunoregulatory axis conducted by skin resident cells","volume":"12","author":"Gao","year":"2021","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.intimp.2023.109945_b0955","doi-asserted-by":"crossref","first-page":"545","DOI":"10.2217\/rme-2016-0037","article-title":"Tissue-engineered human psoriatic skin supplemented with cytokines as an in vitro model to study plaque psoriasis","volume":"11","author":"Pouliot-B\u00e9rub\u00e9","year":"2016","journal-title":"Regen. Med."},{"key":"10.1016\/j.intimp.2023.109945_b0960","doi-asserted-by":"crossref","DOI":"10.3390\/ijms19102923","article-title":"The Tissue-Engineered Human Psoriatic Skin Substitute: A Valuable In Vitro Model to Identify Genes with Altered Expression in Lesional Psoriasis","volume":"19","author":"Rioux","year":"2018","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.intimp.2023.109945_b0965","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2020.119256","article-title":"Development of flavanone and its derivatives as topical agents against psoriasis: The prediction of therapeutic efficiency through skin permeation evaluation and cell-based assay","volume":"581","author":"Alalaiwe","year":"2020","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.intimp.2023.109945_b0970","doi-asserted-by":"crossref","first-page":"91","DOI":"10.2174\/2211738508666200129160027","article-title":"FbD Supported Development and In Vitro Evaluation of Carbomer based Resveratrol Loaded Topical Antipsoriatic Nanoemulgel for its Targeted Skin Delivery","volume":"8","author":"Khurana","year":"2020","journal-title":"Pharm. Nanotechnol."},{"key":"10.1016\/j.intimp.2023.109945_b0975","doi-asserted-by":"crossref","unstructured":"N.H.R. Litjens, E. van Strijen, C. van Gulpen, H. Mattie, J.T. van Dissel, H.B. Thio, P.H. Nibbering, In vitro pharmacokinetics of anti-psoriatic fumaric acid esters., BMC Pharmacol. 4 (2004) 22. https:\/\/doi.org\/10.1186\/1471-2210-4-22.","DOI":"10.1186\/1471-2210-4-22"},{"key":"10.1016\/j.intimp.2023.109945_b0980","doi-asserted-by":"crossref","first-page":"71","DOI":"10.2147\/CIA.S1101","article-title":"A review of tazarotene in the treatment of photodamaged skin","volume":"3","author":"Ogden","year":"2008","journal-title":"Clin. Interv. Aging"},{"key":"10.1016\/j.intimp.2023.109945_b0985","doi-asserted-by":"crossref","DOI":"10.3390\/ph14101058","article-title":"Zebrafish as a Model System to Study the Mechanism of Cutaneous Wound Healing and Drug Discovery: Advantages and Challenges","volume":"14","author":"Naomi","year":"2021","journal-title":"Pharmaceuticals (Basel)"},{"key":"10.1016\/j.intimp.2023.109945_b0990","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.dci.2019.03.018","article-title":"Models of human psoriasis: Zebrafish the newly appointed player","volume":"97","author":"Mart\u00ednez-Navarro","year":"2019","journal-title":"Dev. Comp. Immunol."},{"key":"10.1016\/j.intimp.2023.109945_b0995","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1007\/s12672-022-00511-3","article-title":"The Zebrafish model in dermatology: an update for clinicians","volume":"13","author":"Russo","year":"2022","journal-title":"Discov. Oncol."},{"key":"10.1016\/j.intimp.2023.109945_b1000","article-title":"Modeling Inflammation in Zebrafish for the Development of Anti-inflammatory Drugs., Front. Cell","volume":"8","author":"Xie","year":"2020","journal-title":"Dev. Biol."},{"key":"10.1016\/j.intimp.2023.109945_b1005","doi-asserted-by":"crossref","first-page":"3372","DOI":"10.1242\/jcs.009159","article-title":"Live imaging of chronic inflammation caused by mutation of zebrafish Hai1","volume":"120","author":"Mathias","year":"2007","journal-title":"J. Cell Sci."},{"key":"10.1016\/j.intimp.2023.109945_b1010","doi-asserted-by":"crossref","first-page":"e1001855","DOI":"10.1371\/journal.pbio.1001855","article-title":"Tnfa signaling through tnfr2 protects skin against oxidative stress-induced inflammation","volume":"12","author":"Candel","year":"2014","journal-title":"PLoS Biol."},{"key":"10.1016\/j.intimp.2023.109945_b1015","first-page":"1153","article-title":"Psoriasis regulates epidermal development in zebrafish","volume":"237","author":"Webb","year":"2008","journal-title":"Dev. Dyn. an Off. Publ. Am. Assoc. Anat."},{"key":"10.1016\/j.intimp.2023.109945_b1020","doi-asserted-by":"crossref","first-page":"e1000720","DOI":"10.1371\/journal.pgen.1000720","article-title":"Lgl2 executes its function as a tumor suppressor by regulating ErbB signaling in the zebrafish epidermis","volume":"5","author":"Reischauer","year":"2009","journal-title":"PLoS Genet."},{"key":"10.1016\/j.intimp.2023.109945_b1025","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1016\/j.bbrc.2007.12.084","article-title":"Cloning and characterization of the promoter of Hugl-2, the human homologue of Drosophila lethal giant larvae (lgl) polarity gene","volume":"366","author":"Zimmermann","year":"2008","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.intimp.2023.109945_b1030","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1038\/jid.2010.388","article-title":"Zebrafish: a model system to study heritable skin diseases","volume":"131","author":"Li","year":"2011","journal-title":"J. Invest. Dermatol."},{"key":"10.1016\/j.intimp.2023.109945_b1035","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1242\/dev.032508","article-title":"Lgl2 and E-cadherin act antagonistically to regulate hemidesmosome formation during epidermal development in zebrafish","volume":"136","author":"Sonawane","year":"2009","journal-title":"Development"},{"key":"10.1016\/j.intimp.2023.109945_b1040","doi-asserted-by":"crossref","DOI":"10.3402\/jom.v6.22962","article-title":"Genetic dysbiosis: the role of microbial insults in chronic inflammatory diseases","volume":"6","author":"Nibali","year":"2014","journal-title":"J. Oral Microbiol."},{"key":"10.1016\/j.intimp.2023.109945_b1045","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1186\/s40168-018-0404-9","article-title":"Commensal microbiota modulate gene expression in the skin","volume":"6","author":"Meisel","year":"2018","journal-title":"Microbiome"},{"key":"10.1016\/j.intimp.2023.109945_b1050","doi-asserted-by":"crossref","first-page":"4099","DOI":"10.1038\/s41467-018-06658-4","article-title":"Intestinal microbiome adjusts the innate immune setpoint during colonization through negative regulation of MyD88","volume":"9","author":"Koch","year":"2018","journal-title":"Nat. Commun."},{"key":"10.1016\/j.intimp.2023.109945_b1055","doi-asserted-by":"crossref","first-page":"e0190307","DOI":"10.1371\/journal.pone.0190307","article-title":"Pharmacological activation of TRPV4 produces immediate cell damage and induction of apoptosis in human melanoma cells and HaCaT keratinocytes","volume":"13","author":"Olivan-Viguera","year":"2018","journal-title":"PLoS One"},{"key":"10.1016\/j.intimp.2023.109945_b1060","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1016\/j.jaci.2017.05.051","article-title":"Transient receptor potential vanilloid 4-expressing macrophages and keratinocytes contribute differentially to allergic and nonallergic chronic itch","volume":"141","author":"Luo","year":"2018","journal-title":"J. Allergy Clin. Immunol."},{"key":"10.1016\/j.intimp.2023.109945_b1065","doi-asserted-by":"crossref","unstructured":"A. Montalban-Arques, P. De Schryver, P. Bossier, G. Gorkiewicz, V. Mulero, D.M. 3rd Gatlin, J. Galindo-Villegas, Selective Manipulation of the Gut Microbiota Improves Immune Status in Vertebrates., Front. Immunol. 6 (2015) 512. https:\/\/doi.org\/10.3389\/fimmu.2015.00512.","DOI":"10.3389\/fimmu.2015.00512"},{"key":"10.1016\/j.intimp.2023.109945_b1070","doi-asserted-by":"crossref","first-page":"738","DOI":"10.4049\/jimmunol.1501729","article-title":"TRPV4-Mediated Detection of Hyposmotic Stress by Skin Keratinocytes Activates Developmental Immunity","volume":"196","author":"Galindo-Villegas","year":"2016","journal-title":"J. Immunol."},{"key":"10.1016\/j.intimp.2023.109945_b1075","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1007\/s11248-011-9537-3","article-title":"The construction of transgenic and gene knockout\/knockin mouse models of human disease","volume":"21","author":"Doyle","year":"2012","journal-title":"Transgenic Res."},{"key":"10.1016\/j.intimp.2023.109945_b1080","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1016\/j.jaci.2014.09.005","article-title":"DNA-dependent protein kinase inhibition blocks asthma in mice and modulates human endothelial and CD4+ T-cell function without causing severe combined immunodeficiency","volume":"135","author":"Ghonim","year":"2015","journal-title":"J. Allergy Clin. Immunol."},{"key":"10.1016\/j.intimp.2023.109945_b1085","doi-asserted-by":"crossref","DOI":"10.3390\/ijms20081811","article-title":"The Dynamics of the Skin\u2019s Immune System","volume":"20","author":"Nguyen","year":"2019","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.intimp.2023.109945_b1090","doi-asserted-by":"crossref","unstructured":"C.A. Brohem, L.B. da S. Cardeal, M. Tiago, M.S. Soengas, S.B. de M. Barros, S.S. Maria-Engler, Artificial skin in perspective: concepts and applications., Pigment Cell Melanoma Res. 24 (2011) 35\u201350. https:\/\/doi.org\/10.1111\/j.1755-148X.2010.00786.x.","DOI":"10.1111\/j.1755-148X.2010.00786.x"},{"key":"10.1016\/j.intimp.2023.109945_b1095","doi-asserted-by":"crossref","first-page":"1657","DOI":"10.1177\/1535370217712690","article-title":"Next generation human skin constructs as advanced tools for drug development","volume":"242","author":"Abaci","year":"2017","journal-title":"Exp. Biol. Med. (Maywood)"}],"container-title":["International Immunopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576923002655?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576923002655?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T17:55:07Z","timestamp":1761587707000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1567576923002655"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,4]]},"references-count":219,"alternative-id":["S1567576923002655"],"URL":"https:\/\/doi.org\/10.1016\/j.intimp.2023.109945","relation":{},"ISSN":["1567-5769"],"issn-type":[{"value":"1567-5769","type":"print"}],"subject":[],"published":{"date-parts":[[2023,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Preclinical study models of psoriasis: State-of-the-art techniques for testing pharmaceutical products in animal and nonanimal models","name":"articletitle","label":"Article Title"},{"value":"International Immunopharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.intimp.2023.109945","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"109945"}}